Elsevier Launches New Open Access Journal: Molecular Metabolism

       Elsevier Launches New Open Access Journal: Molecular Metabolism

  PR Newswire

  MUNICH, January 28, 2013

MUNICH, January 28, 2013 /PRNewswire/ --

Elsevier , a world-leading provider of scientific, technical and medical
information products and services, is pleased to announce the launch of
Molecular Metabolism in affiliation with the German Research Center for
Environmental Health (Helmholtz Zentrum München, Munich, Germany) and the
German Center for Diabetes Research (DZD, Germany). Molecular Metabolism is a
new, open access journal devoted to the rapid publication of breakthroughs in
mechanistic metabolism research.

Metabolic diseases including obesity, diabetes and related co-morbidities
remain on the rise. Impaired cellular metabolism is emerging as an etiological
factor for an increasing number of illnesses, such as cancer, cardiovascular
diseases or neurodegenerative disorders. Molecular Metabolism aims to publish
hypothesis-driven research from leading scientists, thus paving the way to a
better understanding of metabolic physiology, and enabling progress toward the
development of personalized medicines for preventing and curing these
metabolism-related diseases.

Matthias Tschöp (Helmholtz Zentrum München and Technische Universität München)
founded the journal together with Jens Brüning (University of Cologne), Tamas
Horvath (Yale University), and Martin Myers (University of Michigan). Their
vision for Molecular Metabolism is an open access journal with a fast track
publication process aiming for peer review-based decisions within one week.
Molecular Metabolism will be able to offer online publication of accepted
manuscripts within 14 days of submission in order to be able to disseminate
breakthrough discoveries in mechanistic and translational metabolism research
with unprecedented speed.

"Translational research is an integral part of the research approach for
investigators around the world. It enables the transformation of knowledge
into medical progress and the realization of the translational potential of
basic research findings for medical applications," said Matthias Tschöp. "
Molecular Metabolism has been launched to provide a home for translational
metabolic disease research, and we welcome submissions from all metabolism
researchers."

Articles published in Molecular Metabolism are freely available to anyone and
are published online on ScienceDirect.

For more information or to submit an article, go to Molecular Metabolism .

About Helmholtz Zentrum München

Helmholtz Zentrum München is the German Research Center for Environmental
Health. It investigates important common diseases, which develop from the
interaction of lifestyle, environmental factors and personal genetic
background, focusing particularly on diabetes mellitus and chronic lung
diseases. The Helmholtz Zentrum München has about 2,000 staff members and is
headquartered in Neuherberg, in the north of Munich. Helmholtz Zentrum
München is a research institution of the Federal Republic of Germany and the
Free State of Bavaria. It is a member of the Helmholtz Association of German
Research Centers , a community of 18 scientific-technical and
medical-biological research centers with a total of about 34,000 staff
members.

About German Center for Diabetes Research (DZD)

The German Center for Diabetes Research (DZD) is a national network comprised
of experts in the field of diabetes research that connects basic research,
epidemiology and clinical applications. Members of the network are Helmholtz
Zentrum München, the German Diabetes Center in Düsseldorf, the German
Institute for Human Nutrition in Potsdam-Rehbrücke, Paul Langerhans Institute
of the Carl Gustav Carus University Hospital in Dresden and the Institute for
Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München at
the University of Tübingen. The goal of the DZD is to find answers to unsolved
questions in diabetes research via an innovative, integrative research
approach and to make a major contribution to improving the prevention,
diagnosis, and therapy of diabetes mellitus ( http://www.dzd-ev.de/en )

Open Access Publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today,
researchers can choose to publish in over 1,500 hybrid journals as well as
more than 30 full open access journals and these numbers will continue to grow
rapidly. All of Elsevier's open access publications have been peer reviewed,
ensuring that the broader community not only reads the latest research but
that it is factual, original and of the highest quality and ethical standards.
For more information about Elsevier's open access program, visit
http://www.elsevier.com/openaccess

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet and Cell , and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect , Scopus , Reaxys , ClinicalKey and Mosby's Nursing
Suite , which enhance the productivity of science and health professionals,
and the SciVal suite and MEDai's Pinpoint Review , which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
provider of professional information solutions in the Science, Medical, Legal
and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and
Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London
Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Adriaan Klinkenberg Elsevier +49-174-344-2319
f.klinkenberg@elsevier.com
 
Press spacebar to pause and continue. Press esc to stop.